Physician

Allen Jeremias, M.D.

According to 2025 Medicare claims, Allen Jeremias, M.D. (NPI: 1427138395) practices interventional cardiology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is CHS PHYSICIAN PARTNERS, P.C (NPI: 1164585725; TIN: 113613997) and primary practice location at 11576-1347. Jeremias is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Jeremias' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 550 traditional Medicare patients, billed 2,146 HCPCS/CPT codes, and received $278,897 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 2,831 prescription claims across 405 beneficiaries totaling $773,209 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 11 claims. Open Payments data shows 122 records totaling $210,841. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $180,238 to $278,897. Similarly, Part D prescription costs have moved sharply higher in recent years, from $50,519 to $773,209. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	440	1,040	$180,238
2016	403	931	$161,181
2017	427	1,425	$178,261
2018	442	1,453	$171,612
2019	614	2,026	$247,729
2020	601	1,965	$249,083
2021	563	2,172	$295,497
2022	615	2,292	$294,076
2023	575	2,213	$285,241
2024	550	2,146	$278,897

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	121	830	$50,519
2016	129	835	$57,821
2017	171	767	$73,735
2018	200	927	$131,366
2019	275	1,393	$184,271
2020	278	1,522	$276,607
2021	294	1,673	$340,634
2022	357	2,325	$511,291
2023	379	2,539	$626,149
2024	405	2,831	$773,209

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	11	$25,600
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	104	107	$224
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	424	602	$109
92978	Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel	121	139	$90
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	88	282	$71
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	268	384	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	127	7,665	$147,484
Entresto	Sacubitril/Valsartan	93	5,457	$119,778
Camzyos	Mavacamten	14	395	$112,961
Xarelto	Rivaroxaban	63	4,140	$73,923
Farxiga	Dapagliflozin Propanediol	48	2,743	$50,536

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$114,501	Philips North America LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$96,340	M.A. Med Alliance S.A.
Ownership / Investment Interests	Reported value of ownership or investment interests.	1	$200,712	SpectraWAVE, Inc

Explore More Providers

FAQ

What Medicare data is available for Allen Jeremias, M.D.?

Tedicare shows public-source Medicare data for Allen Jeremias, M.D. (NPI 1427138395), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Allen Jeremias, M.D. have ACO affiliation data?

Allen Jeremias, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Allen Jeremias, M.D.?

Allen Jeremias, M.D. is linked to CHS PHYSICIAN PARTNERS, P.C (billing NPI 1164585725) in the available physician profile data.

Does Allen Jeremias, M.D. have Open Payments data?

Allen Jeremias, M.D. has 122 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.